Clinical Trial Update: Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 trial analyzed how chronic kidney disease affects clopidogrel in patients with type 2 diabetes, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: University of Florida | Conditions: Chronic Kidney Disease (CKD), Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Status: COMPLETED | Results posted: 2023-08-21